American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 4 , Pages 329-337 , July 2011

Diagnosis and treatment of primary immunodeficiency disease: the role of the otolaryngologist

  • Richard L. Wasserman, MD, PhD

      Affiliations

    • Dallas Allergy Immunology, Dallas, TX, USA
    • Corresponding Author InformationCorresponding author. Dallas Allergy Immunology, 7777 Forest Ln, Suite B-332, Dallas, TX 75230, USA. Tel.: +1 972 566 7788; fax: +1 972 566 8837.
    • ,
  • Scott C. Manning, MD

      Affiliations

    • W-7729-Otolaryngology-ENT, Seattle, WA, USA

Received 5 February 2010

References 

  1. Geha RS, Notarangelo LD, Casanova JL, et al. for the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–794
  2. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497–502
  3. Joshi AY, Iyer VK, Hagan JB, et al. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc. 2009;84:16–22
  4. Immune Deficiency Foundation . Diagnostic and clinical care guidelines for primary immunodeficiency diseases. Available at: http://www.primaryimmune.org/publications/book_diag/IDF_Diagnostic_and_Clinical_Care_Guidelines-Final.pdf2006;Accessed October 6, 2008
  5. Yarmohammadi H, Estrella L, Doucette J, et al. Recognizing primary immune deficiency in clinical practice. Clin Vaccine Immunol. 2006;13:329–332
  6. Cunningham-Rundles C, Knight AK. Common variable immune deficiency: reviews, continued puzzles, and a new registry. Immunol Res. 2007;38:78–86
  7. In:  Stiehm ER,  Ochs HD,  Winkelstein JA editor. Immunologic disorders in infants and children. 5th ed.. Philadelphia (PA): Elsevier Saunders; 2004;
  8. Manning SC, Wasserman RL, Leach J, et al. Chronic sinusitis as a manifestation of primary immunodeficiency in adults. Am J Rhinol. 1994;8:29–36
  9. Bonilla FA, Bernstein IL, Khan DA, et al. and the American Academy of Allergy, Asthma, and Immunology; the American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(Suppl 1):S1–63
  10. Immune Deficiency Foundation . Primary immune deficiency diseases in America: 2002. The second national survey of patients. Available at: http://www.primaryimmune.org/publications/surveys/second_national_survey_of_patients_(2002).pdf2002;Accessed October 6, 2008
  11. Primary Immunodeficiency Resource Center . 10 warning signs of primary immunodeficiency. Available at: http://www.info4pi.org/patienttopatient/pdf/10_warnings_poster_eng.pdf2008;Accessed October 7, 2008
  12. Cooney TR, Huissoon AP, Powell RJ, et al. Investigation for immunodeficiency in patients with recurrent ENT infections. Clin Otolaryngol Allied Sci. 2001;26:184–188
  13. Stiehm ER. The four most common pediatric immunodeficiencies. J Immunotoxicol. 2008;5:227–234
  14. Wood P, Stanworth S, Burton J, et al. UK Primary Immunodeficiency Network. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149:410–423
  15. Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308–316
  16. Oksenhendler E, Gerard L, Fieschi C, et al. Infections in 252 patients with common variable immunodeficiency. Clin Infect Dis. 2008;46:1547–1554
  17. Bondioni MP, Duse M, Plebani A, et al. Pulmonary and sinusal changes in 45 patients with primary immunodeficiencies: computed tomography evaluation. J Comput Assist Tomogr. 2007;31:620–628
  18. Urschel S, Kayikci L, Wintergerst U, et al. Common variable immunodeficiency disorders in children: delayed diagnosis despite typical clinical presentation. J Pediatr. 2009;154:888–894
  19. Shapiro GG, Virant FS, Furukawa CT, et al. Immunologic defects in patients with refractory sinusitis. Pediatrics. 1991;87:311–316
  20. Chee L, Graham SM, Carothers DG, et al. Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope. 2001;111:233–235
  21. Baraniuk JN, Maibach H. Pathophysiological classification of chronic rhinosinusitis. Respir Res. 2005;6:149
  22. Vanlerberghe L, Joniau S, Jorissen M. The prevalence of humoral immunodeficiency in refractory rhinosinusitis: a retrospective analysis. B-ENT. 2006;2:161–166
  23. Mynatt RG, Do J, Janney C, et al. Squamous metaplasia and chronic rhinosinusitis: a clinicopathological study. Am J Rhinol. 2008;22:602–605
  24. Manning SC. Surgical management of sinus disease in children. Ann Otolaryngol Rhinol Laryngol Suppl. 1992;155:42–45
  25. Eades-Perner AM, Gathmann B, Knerr V, et al. and the ESID Registry Working Party The European Internet-based patient and research database for primary immunodeficiencies: results 2004-06. Clin Exp Immunol. 2007;147:306–312
  26. Seymour B, Miles J, Haeney M. Primary antibody deficiency and diagnostic delay. J Clin Pathol. 2005;58:546–547
  27. Verbsky JW, Grossman WJ. Cellular and genetic basis of primary immune deficiencies. Pediatr Clin North Am. 2006;53:649–684
  28. World Health Organization . Primary immunodeficiency diseases. Report of a WHO scientific group. Clin Exp Immunol. 1997;(Suppl 1):1–28
  29. Ballow M. Primary immunodeficiency disorders. J Allergy Clin Immunol. 2002;109:581–591
  30. Shackelford PG, Granoff DM, Madassery JV, et al. Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res. 1990;27:16–21
  31. Herrod HG. Clinical significance of IgG subclasses. Curr Opin Pediatr. 1993;5:696–699
  32. Bonilla FA, Geha RS. Primary immunodeficiency diseases. J Allergy Clin Immunol. 2003;111:S571–S581
  33. Rosenzweig SD, Holland SM. Phagocyte immunodeficiencies and their infections. J Allergy Clin Immunol. 2004;113:620–626
  34. Berger M. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am. 2008;28:413–437
  35. Orange JD, Hossny EM, Weiler CR, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117:S525–S553
  36. Bonagura VR, Marchlewski R, Cox A, et al. Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J Allergy Clin Immunol. 2008;122:210–212
  37. Bruton OC. Agammaglobulinemia. Pediatrics. 1952;9:722–728
  38. Berger M, Cupps TR, Fauci AS. Immunoglobulin replacement therapy by slow subcutaneous infusion. Ann Intern Med. 1980;93:55–56
  39. Immune Deficiency Foundation . Treatment experiences and preferences of patients with primary immune deficiency diseases: first national survey. Available at: http://www.primaryimmune.org/publications/surveys/Treatment_Experiences_and_Preferences_(2003).pdf2003;Accessed October 20, 2008
  40. Gardulf A, Nicolay U, Asensio O, et al. Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies—a prospective, multi-national study. J Clin Immunol. 2006;26:177–185
  41. Ochs HD, Gupta S, Kiessling P, et al. and the Subcutaneous IgG Study Group Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J Clin Immunol. 2006;26:265–273
  42. Gardulf A, Hammarström L, Smith CI. Home treatment of hypogammaglobulinaemia with subcutaneous gammaglobulin by rapid infusion. Lancet. 1991;338:162–166
  43. Gardulf A, Björvell H, Andersen V, et al. Lifelong treatment with gammaglobulin for primary antibody deficiencies: the patients' experiences of subcutaneous self-infusions and home therapy. J Adv Nurs. 1995;21:917–927
  44. Chapel HM, Spickett GP, Ericson D, et al. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J Clin Immunol. 2000;20:94–100
  45. United States Food and Drug Administration . Product approval information—licensing action. Available at: http://www.fda.gov/CBER/approvltr/igsczlb010906L.htm2006;Accessed October 9, 2008
  46. Berger M. Subcutaneous immunoglobulin replacement in primary immunodeficiencies. Clin Immunol. 2004;112:1–7
  47. Gaspar J, Gerritsen B, Jones A. Immunoglobulin replacement treatment by rapid subcutaneous infusion. Arch Dis Child. 1998;79:48–51
  48. Dollery CM, Sullivan ID, Bauraind O, et al. Thrombosis and embolism in long-term central venous access for parenteral nutrition. Lancet. 1994;344:1043–1045
  49. Misbah SA, Chapel HM. Adverse effects of intravenous immunoglobulin. Drug Saf. 1993;9:254–262
  50. Davé S, Hagan J. Myocardial infarction during intravenous immunoglobulin infusion in a 65-year-old man with common variable immunodeficiency and subsequent successful repeated administration. Ann Allergy Asthma Immunol. 2007;99:567–570
  51. Orbach H, Katz U, Sherer Y, et al. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol. 2005;29:173–184
  52. Hefer D, Jaloudi M. Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature. Ann Hematol. 2004;83:661–665
  53. Horn J, Thon V, Bartonkova D, et al. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy. Clin Immunol. 2007;122:156–162
  54. Eijkhout HW, van den Broek PJ, van der Meer JW. Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy. Neth J Med. 2003;61:213–217
  55. Shapiro R. Rapid push of immune globulin replacement therapy is preferred to pump in patients with primary immune deficiency: a retrospective study in one clinic. In: Poster presented at American Academy of Allergy, Asthma, and Immunology; March 13-17, 2009; Washington, DC. 2009;
  56. Gardulf A, Andersen V, Björkander J, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet. 1995;345:365–369
  57. Björkander J, Bake B, Hanson LA. Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment. Eur J Respir Dis. 1984;65:529–536
  58. Roifman CM, Levison H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet. 1987;1:1075–1077
  59. Plebani A, Soresina A, Rondelli R, et al. and the Italian Pediatric Group for XLA-AIEOP Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol. 2002;104:221–230
  60. Johnston SL, Hill SJ, Lock RJ, et al. Echocardiographic abnormalities in primary antibody deficiency. Postgrad Med J. 2004;80:214–218
  61. Boyle ML, Scalchunes C. Impact of intravenous immunoglobulin (IVIG) treatment among patients with primary immunodeficiency disease. Pharm Policy Law. 2008;10:133–146
  62. Gardulf A, Björvell H, Gustafson R, et al. The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions. Clin Exp Immunol. 1993;92:200–204
  63. Gardulf A, Nicolay U, Asensio O, et al. Children and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at home. J Allergy Clin Immunol. 2004;114:936–942
  64. Fasth A, Nyström J. Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin. J Clin Immunol. 2008;28:370–378
  65. Nicolay U, Kiessling P, Berger M, et al. Health-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at home. J Clin Immunol. 2006;26:65–72

PII: S0196-0709(10)00085-2

doi: 10.1016/j.amjoto.2010.05.001

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 32, Issue 4 , Pages 329-337 , July 2011

Article Tools

* Image Usage & Resolution